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ABSTRACT
Introduction Reaching men aged 20–35 years, the group at 
greatest risk of HIV, with voluntary medical male circumcision 
(VMMC) remains a challenge. We assessed the impact of two 
VMMC demand creation approaches targeting this age group 
in a randomised controlled trial (RCT).
Methods We conducted a 2×2 factorial RCT comparing 
arms with and without two interventions: (1) standard 
demand creation augmented by human- centred design 
(HCD)- informed approach; (2) standard demand creation plus 
offer of HIV self- testing (HIVST). Interpersonal communication 
(IPC) agents were the unit of randomisation. We observed 
implementation of demand creation over 6 months (1 May 
to 31 October 2018), with number of men circumcised 
assessed over 7 months. The primary outcome was the 
number of men circumcised per IPC agent using the as- 
treated population of actual number of months each IPC 
agent worked. We conducted a mixed- methods process 
evaluation within the RCT.
Results We randomised 140 IPC agents, 35 in each arm. 
132/140 (94.3%) attended study training and 105/132 
(79.5%) reached at least one client during the trial period 
and were included in final analysis. There was no evidence 
that the HCD- informed intervention increased VMMC uptake 
versus no HCD- informed intervention (incident rate ratio (IRR) 
0.87, 95% CI 0.38 to 2.02; p=0.75). Nor did offering men a 
HIVST kit at time of VMMC mobilisation (IRR 0.65, 95% CI 0.28 
to 1.50; p=0.31). Among IPC agents that reported reaching at 
least one man with demand creation, both the HCD- informed 
intervention and HIVST were deemed useful. There were 
some challenges with trial implementation; <50% of IPC 
agents converted any men to VMMC, which undermined our 
ability to show an effect of demand creation and may reflect 
acceptability and feasibility of the interventions.
Conclusion This RCT did not show evidence of an 
effect of HCD- informed demand intervention or HIVST 
on VMMC uptake. Findings will inform future design and 
implementation of demand creation evaluations.
Trial registration number PACTR201804003064160.
INTRODUCTION
Voluntary medical male circumcision 
(VMMC) is one of five key HIV prevention 
Key questions
What is already known?
 ► Reaching men 20–35 years old, the age group at 
greatest risk of HIV, with voluntary medical male 
circumcision (VMMC) for HIV prevention remains a 
challenge.
What are the new findings?
 ► Demand creation intervention informed by human- 
centred design (HCD, fully involves intended bene-
ficiaries in intervention design) and HIV self- testing 
(HIVST) trialled here did not have an impact on 
VMMC uptake.
 ► Suboptimal implementation of the HCD- informed 
and HIVST interventions may reflect feasibility of im-
plementation in practice and reduced the power of 
the trial to show an impact.
What do the new findings imply?
 ► Demand creation using HCD- informed approach 
and/or HIVST did not overcome all barriers to adult 
men’s VMMC uptake.
 ► Additional efforts and innovative demand creation 
approaches are required to overcome the opportu-
nity costs men are likely to incur.
 ► Evaluations of real- world interventions continue to 
be affected by real life challenges to implementation 
including a lack of control of the manner in which 
interventions are implemented.
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strategies aiming to reduce new HIV infections by 75%.1 
By December 2019, nearly 27 million adolescent and adult 
men (≥10 years) had been circumcised and an estimated 
340 000 new infections averted in 15 VMMC priority 
countries, including 260 000 infections among men and 
75 000 among women (due to reduced secondary trans-
mission from men).2 3 However, the majority of those 
circumcised were adolescent boys (10–19 years); reaching 
adult men aged 20–35 years, who are the age group at 
greatest risk of HIV, remains a challenge.4–8 Strategies 
to increase VMMC demand among adult men including 
financial incentives, counselling or education, involve-
ment of influencers and novel information delivery, have 
had mixed results.9 There have been calls for innovative 
and robust VMMC demand creation strategies to reach 
adult men.9–14
Within sub- Saharan Africa, barriers to VMMC uptake 
include the restricted number of service delivery sites 
and limited numbers of healthcare workers available to 
perform the procedure.15 Attrition of trained staff is an 
additional challenge.16 Men traditionally access health-
care less than women, and this might be further exacer-
bated by masculine norms that equate help- seeking with 
being ‘weak’.17–19 Other barriers include poor percep-
tion of HIV risk20–22 and fear of: pain, surgical complica-
tions, preoperative HIV testing20 21 23 and costs (including 
opportunity costs).10 11 Previous research suggested that 
preoperative HIV testing was a significant barrier to 
VMMC uptake as many men reported being concerned 
about pre- VMMC testing at a VMMC site when deductive 
disclosure may occur in the event they are HIV positive.20 
Researchers then hypothesised that if men self- tested 
and knew their status in advance of going to the VMMC 
centre, this would overcome their fear of testing for the 
first time at the VMMC site (even if it meant being tested 
again).24 25 Strategies to overcome the other barriers are 
required if the intervention is to be brought to desired 
scale.
In 2015, market research was undertaken in Zimbabwe 
to systematically understand the journey from initial 
awareness of VMMC, to undergoing the procedure and 
in turn becoming a ‘VMMC advocate’, as well as how that 
journey varies across types (or segments) of men.26–28 This 
research mapped the decision- making path men take to 
VMMC, identifying key triggers for demand and strate-
gies that can be adopted to address the intend- to- action 
gap. It also used a hybrid psychographic- behavioural 
segmentation approach to profile men according to 
their perceptions about and orientation to VMMC.26–28 
Through this market research, six ‘segments’ of men 
were identified based on their attitudes to and motiva-
tions for VMMC. The research also identified factors 
driving the cognitive dissonance (conflicting attitudes, 
beliefs or behaviours) impeding VMMC uptake among 
some segments of men.26 28
Based on this market research, the largest VMMC 
implementer in Zimbabwe (Population Services Inter-
national (PSI)) prioritised three segments of men for 
demand creation interventions, who represented 56% of 
uncircumcised males aged 15–29 years in Zimbabwe at 
that time. The three prioritised segments were: VMMC 
enthusiasts (21%, have a high potential to undergo 
VMMC and strong commitment already—although need 
to overcome some dissonance in order to proceed); 
neophytes (19%, potentially enthusiastic but poor knowl-
edge undermines their commitment—addressing this 
would be relatively straightforward and likely result in 
increased VMMC uptake) and embarrassed rejecters (16%, 
potentially interested but with little commitment and 
knowledge, embarrassment and fears are high—so need 
lots of support to undergo VMMC).26 28
Drawing on market research findings, interpersonal 
communication (IPC) demand creation was redesigned 
to encompass a human- centred design (HCD)- informed 
approach. IPC agents who act as community mobilisers 
for VMMC were trained to conduct one- on- one sessions 
with potential VMMC clients using three tools: a segmen-
tation typing tool, segment- specific targeted messaging 
and a pain- o- metre (visual aid) to guide discussions 
related to pain (see online supplemental appendix for 
detailed descriptions).
Here, we present results of a randomised controlled 
trial (RCT) that assessed the effectiveness of this 
HCD- informed approach in motivating 15- year- old to 
29- year- old men (Zimbabwe’s VMMC priority age group) 
to take up VMMC. In addition, we explored whether 
providing access to HIVST would result in increased 
VMMC uptake. We hypothesised that potential VMMC 
clients mobilised: (1) using the HCD- informed interven-
tion would have increased circumcision uptake compared 
with those mobilised using standard techniques and (2) 
with the offer of HIVST would have increased circumci-
sion uptake compared with those mobilised without the 
offer of HIVST.
METHODS
Study design and setting
We conducted a 2×2 factorial pragmatic RCT comparing 
arms with and without two interventions: (1) standard 
demand creation augmented by HCD- informed 
approach; (2) standard demand creation plus offer of 
HIVST.
We conducted the study in five districts (Buhera, 
Gokwe North, Mangwe, Mutasa, Zvimba), in 4 of 10 
provinces in Zimbabwe. Neither interventions had 
been implemented in these districts before the trial. 
The interventions were implemented by IPC agents, 
all of whom had at least some secondary education. 
To guard against the risk of contamination, each IPC 
agent was assigned a ward (subdivision of district) and 
required to work within the confines of their ward.
Outcomes were measured using monthly VMMC 
programme outputs collected by these agents and VMMC 
clinics.
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CONSORT guidelines for RCT29 reporting were 
followed. Three changes were made to the trial 
protocol after trial commencement. First, the inter-
vention run- in period was extended to allow more 
time for the IPC agents to become comfortable with 
the HCD- informed approach. Second, following review 
of blinded interim data, the sample size was recalcu-
lated and the main analysis was changed from parallel 
comparisons to the two factorial comparisons, assessing 
outcomes with and without each intervention. Third, 
it was necessary to change the statistical model docu-
mented in the initial analysis plan to accommodate 
extremely high variability of outcomes between and 
within IPC agents; a more valid approach was used. 
These changes are summarised in detail in the online 
supplemental appendix.
For each study arm, training was conducted over 
2 days from 1 to 8 February 2018 and implementation 
started straight after with a closely supervised run- in 
period from 20 February to 30 April 2018. By 30 April, 
implementers were confident that all IPC agents were 
able to implement demand creation as assigned. The 
interventions were implemented over 6 months (1 May 
to 31 October 2018) and counting number of circumci-
sions conducted over 7 months (1 May to 30 November 
2018), allowing the last man enrolled on 31 October 
to have 1 month to be circumcised. This minimum 
follow- up is in keeping with the implementer’s expe-
rience that men wanting to be circumcised will do so 
within 1 month of referral.
Client involvement
The interventions were optimised for this setting using 
formative work undertaken in 2017 with VMMC clients 
and IPC agents. For example, during the formative 
work, it was observed that IPC agents did not know how 
to categorise men who were clearly willing to be circum-
cised prior to segmentation. Consequently, the imple-
menter created an additional segment (‘green’—a 
default segment which denoted that client was willing 
to be circumcised before the start of the demand crea-
tion session and therefore no proper segmentation was 
done).
Randomisation and masking
IPC agents were the unit of randomisation and were 
assigned 1:1:1:1 to four arms, using restricted randomi-
sation by IPC agent for sex, age and having ≥12 months 
of VMMC mobilisation experience. The random alloca-
tion of IPC agents to intervention arms was completed 
using random- number tables generated in Stata by a 
study statistician on 25 January 2018.
Neither IPC agents nor clients could be masked to allo-
cation. The statistician conducting the primary analysis 
was masked to allocation for the planned primary and 
secondary analyses. Subsequent analyses were conducted 
on unmasked data.
Intervention components
Arm 1: standard demand creation
IPC agents received basic training on how to promote 
VMMC, including identifying barriers, clarifying myths 
and misconceptions and summarising key benefits. Men 
were mobilised for VMMC individually or in groups. 
Clients referred for VMMC either went to VMMC sites 
on their own or were taken there in a programme 
vehicle.
Arm 2: standard demand creation plus offer of HIVST
In addition to standard demand creation, IPC agents 
offered the men they mobilised a HIVST kit, with a kit 
use demonstration if accepted.
Arm 3: HCD-informed demand creation approach
IPC agents received basic training in the HCD- 
informed approach, including using the segmentation 
typing tool, to prioritise the three key segments. They 
then delivered messages tailored to that ‘segment’. IPC 
agents were specifically required to address any pain- 
related concerns using a visual aid (pain- o- metre) to 
outline the VMMC procedure, healing process, as well 
as possible pain management techniques. Men in the 
non- prioritised segments received general (as opposed 
to tailored) messages.
As already stated, if a client was willing to be circum-
cised at the start of the discussion, segmentation was 
skipped and these men were allocated to a default 
‘segment’ (green), which was not developed from the 
market research. Clients mobilised in groups at schools 
were also allocated to the ‘green’ segment.
Arm 4: HCD-informed demand creation approach plus offer of 
HIVST
In this arm, in addition to the HCD- informed demand 
creation approach, IPC agents offered the men they 
mobilised a HIVST kit, with a kit use demonstration if 
accepted.
Additional procedures—all arms
After a mobilisation session, each client was asked to 
provide his contact details to allow the IPC agent to 
provide supportive follow- up. All men who were referred 
for VMMC were given a referral card with a unique 
identifier and asked to present it when they attended 
for VMMC, enabling their attendance to be linked with 
the referring IPC agent. District Field Officers (IPC 
agents’ supervisors) checked concordance between 
IPC agents and facility records, which helped curb 
fraud in payments to IPCs. The RCT payment structure 
followed that of the national VMMC programme, with 
IPC agents receiving US$5 when a boy aged 10–14 years 
or a man ≥30 years was circumcised and US$7 when 
a man aged 15–29 years was circumcised. IPCs only 
received an incentive if the person they reached and 
referred was actually circumcised.
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Process evaluation
We conducted a mixed- methods process evaluation 
within the trial. Data included: programme data; 
observations of IPC agents conducting VMMC mobi-
lisation sessions; in- depth interviews (IDIs) and focus 
group discussions (FGDs) with IPC agents; IDIs with 
PSI’s District Field Officers; and FGDs with men mobi-
lised for VMMC. Iterative qualitative data collection 
and analysis informed a grounded thematic analytical 
approach.
Outcome measures
The primary outcome was the number of men circum-
cised per IPC agent over the 6- month duration of 
the trial and compared by arm. Secondary outcomes 
were: (i) the mean conversion proportion (conversion 
proportion defined as number of men circumcised 
divided by the number of men reached by IPC agents); 
secondary outcomes (ii)–(vii) are shown in figure 1. 
In addition, there were three HIVST- related outcomes 
measured in the two HIVST arms (figure 1).
Programme data collected from IPC agents and clinic 
data were used to evaluate the primary outcome and 
secondary outcomes (i)–(iv). For ST outcomes (v)–
(vii), IPC agents recorded whether the man opted to 
take a kit. Additional data on HIVST use were obtained 
from a phone- administered follow- up questionnaire 
with clients.
Sample size calculation
As originally designed, this study required 35 IPC 
agents per arm (140 IPC agents across four arms) to 
have 80% power to detect a 30% proportionate differ-
ence in VMMC uptake between any two individual 
arms assuming a high variability between IPC agents 
(coefficient of variation, k=0.3) (see online supple-
mental appendix for other scenarios). A revised power 
calculation was completed in October 2018, using a 
higher k (1.0) to reflect high measured clustering 
within the outcome data collected to that point. This 
sample size calculation found that with 65 IPC agents 
per arm and two arms, we had 80% power to detect 
between 90% increase in VMMC per intervention (eg, 
10.5–20). This resulted in the change from parallel 
comparisons to factorial- arm comparisons, assessing 
outcomes with and without each intervention.
Statistical analysis
Analysis used intention- to- treat (ITT) and as- treated 
populations. The as- treated analysis population was 
based on the actual number of months each IPC 
agent worked, restricted to agents who reached at 
least one client, and included 20 IPC agents who the 
implementer added postrandomisation to replace 
20 randomised IPC agents who declined to take 
part before training. The ITT analysis population 
was as defined based on the intended 6 months of 
Figure 1 Primary outcome and secondary outcomes (ii)–(vii). HIVST, HIV self- testing; IPC, interpersonal communication; 
VMMC, voluntary medical male circumcision.
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mobilisation time each IPC agent was to work and 
excluded the 20 IPC agents added by the implementer 
postrandomisation.
The study team and the independent Technical 
Advisory Group (TAG) viewed the ‘as- treated’ anal-
ysis as the most appropriate for understanding the 
real- world effectiveness of the intervention and was 
therefore considered the primary analysis. This anal-
ysis compared outcomes with and without each inter-
vention (factorial- arm analysis).
A statistical analysis plan (SAP) was developed prior 
to analysis; however, because the prespecified model-
ling approach was not valid statistically, the SAP was 
revised both during data collection and after the 
initial analysis was complete with input from the TAG. 
For the primary outcome, the effect of study arm was 
assessed at the IPC agent level using negative bino-
mial regression. Subgroup analyses were performed 
to assess the differences in impact of the outcome by 
client age. These analyses were prespecified as 15–19 
years, 20–29 years and 30+ years and then an addi-
tional post hoc analysis of 18–19 year- olds.
Conversion proportion per IPC was modelled using 
logistic regression. Secondary outcomes (ii)–(iv) were 
analysed at the same IPC agent- level data using negative 
binomial regression, while secondary outcomes related 
to self- test use were analysed using logistic regression.
All analyses were repeated using parallel- arm compar-
isons as well as ITT and as- treated populations. HIVST 
outcomes were compared by study arm 2 and 4 at the 
client level, using data arising from the as- treated anal-
ysis population.
Analyses were done with STATA V.15.1 software 
(StataCorp).
RESULTS
One hundred and forty- three IPC agents were iden-
tified by PSI for the trial, 140 were randomly chosen 
and allocated to one of four study arms. Postrandomi-
sation, 20 declined to take part before training and 
were replaced with IPC agents by the implementer. 
One hundred and thirty- two of 140 (94.3%) attended 
study arm- specific training and 105/132 (79.5%) 
reported reaching at least one client during the trial 
period and were included in the ‘as- treated’ anal-
ysis. IPC agent attrition ranged from 4 (11.8%) to 11 
(33.3%) by arm and was highest in arm 4 (figure 2).
Characteristics of IPC agents
There were differences in characteristics of IPC agents 
by arm resulting from replacement of 20 IPCs postran-
domisation and included differences in age, gender, 
level of education and prior VMMC mobilisation expe-
rience (table 1).
Characteristics of clients reached
Overall, 105 IPC agents reached 8707 men with 
demand creation for VMMC. Arm 1 (SOC) reached 
the greatest number of clients (n=3105, 35.7%) while 
arm 4 (HCD+ST) reached the smallest (n=1542, 
17.7%) (table 2). The majority of potential VMMC 
clients were out of school, across all the arms (table 2). 
Overall, 84.5% (7356/8707) of men reached were 
aged 15–29 years.
Figure 2 CONSORT diagram for as- treated analysis population. HCD, human- centred design; IPC, interpersonal 
communication; SOC standard of care; ST self- testing.
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Effect of HCD-informed intervention on VMMC uptake (as-
treated analysis population)
For the primary outcome, there was no evidence that the HCD- 
informed intervention increased VMMC uptake (incident 
rate ratio (IRR) 0.87, 95% CI 0.38 to 2.02; p=0.75) (figure 3 
and online supplemental table 1). There was no evidence 
of an interaction effect between HCD- informed intervention 
and age for VMMC uptake (p=0.27). The HCD- informed 
Table 1 Characteristics of IPC agents by arm (as- treated analysis population)
Arm 1: SOC Arm 2: ST Arm 3: HCD Arm 4: HCD+ST
n % n % n % n %
IPC agents 29 27 27 22
Total IPC mobilisation—months 126 96 101 97
Male 8 27.6 17 63.0 15 55.6 8 36.4
District
  Buhera 6 20.7 8 29.6 2 7.4 9.1
  Gokwe North 4 13.8 9 33.3 4 14.8 40.9
  Mangwe 4 13.8 1 3.7 3 11.1 13.6
  Mutasa 5 11.1 3 11.1 11 40.7 31.8
  Zvimba 10 34.5 6 22.2 7 25.9 4.6
Age (years)
  ≤19 1 3.5 1 3.7 4 14.8 1 4.6
  20–29 4 13.8 12 44.5 6 22.2 5 22.7
  30–39 7 24.1 8 29.6 4 14.8 2 9.1
  40–49 9 31.0 5 18.5 9 33.4 13 59.0
  50+ 8 27.6 1 3.7 4 14.8 1 4.6
Educational level
  Primary level 8 27.6 1 3.7 1 3.7 0 0
  Secondary level 15 51.7 23 85.2 25 92.6 22 100
  ≥Advanced level 6 20.7 3 11.1 1 3.7 0 0
IPC experience
  <12 months 22 75.9 18 66.7 21 77.8 9 40.9
  ≥12 months 7 24.1 9 33.3 6 22.2 3 59.1
  Mean/median IPC mobilisation months 4.2/4 3.7/4 3.8/3 4.4/5
HCD, human- centred design; IPC, interpersonal communication; SOC, standard of care; ST, self- testing.
Table 2 Characteristics of ≥15- year- olds clients reached by arm (as- treated analysis population)
Arm 1: SOC Arm 2: ST Arm 3: HCD Arm 4: HCD+ST
n % n % n % n %
Total 3105 100 1754 100 2306 100 1542 100
Age in years
  15–17 1102 35.5 592 33.8 886 38.4 509 33.0
  18–19 571 18.4 318 18.1 523 22.7 278 18.0
  20–29 952 30.7 440 25.1 627 27.2 558 36.2
  30+ 480 15.4 404 23.0 270 11.7 197 12.8
  Median age (min- max), years 19.0 (15-78) 19.0 (15-87) 18.0 (15-84) 19.0 (15-83)
Education completed*
  School- going 1232 40.1 638 39.6 728 31.8 477 31.5
  Out of school 1841 59.9 1041 60.4 1560 68.2 1039 68.5
*106 missing.
HCD, human- centred design; SOC, standard of care; ST, self- testing.
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approach had no effect on secondary outcomes of: VMMC 
conversion proportion (risk ratio (RR) 0.75, 95% CI 0.41 to 
1.38; p=0.36), the number of men reached (IRR 0.89, 95% CI 
0.62 to 1.26; p=0.50), the number of men booked for VMMC 
(IRR 1.00, 95% CI 0.62 to 1.60; p>0.99) or the number of 
men presenting for VMMC (IRR 1.00, 95% CI 0.48 to 2.06; 
p>0.99). Overall, of all reached in the HCD arms, 12.6% 
(485/3848) were classified in the default ‘green’ segment, 
denoting that client was willing to be circumcised before the 
start of the demand creation session.
Effect of HIVST intervention on VMMC uptake
Offering men a HIVST kit at the time of VMMC mobilisation 
did not have an effect on VMMC uptake (IRR 0.65, 95% CI 
0.28 to 1.50; p=0.31) (figure 4 and online supplemental 
table 1). There was also no effect of offer of a HIVST kit on 
secondary outcomes of: the conversion proportion (RR 1.11, 
95% CI 0.61 to 2.02; p=0.71); the number of men reached 
(IRR 0.75, 95% CI 0.53 to 1.07; p=0.11), booked (IRR 0.80, 
95% CI 0.50 to 1.29; p=0.36) or presenting for VMMC at the 
clinic (IRR 0.84, 95% CI 0.40 to 1.73; p=0.63). There was no 
evidence of an effect of an offer of HIVST on VMMC uptake 
in any age category although there was doubling of VMMC 
uptake among men over 30 years, although the CI included 
one (figure 4). There was no evidence of an interaction 
effect between HIVST intervention and age (p=0.21).
ITT analysis also showed no evidence of an effect of 
HCD- informed and HIVST approaches on VMMC uptake 
(see online supplemental table 2).
Figure 3 Effect of HCD- informed intervention—as- treated analysis population. HCD, human- centred design; VMMC, 
voluntary medical male circumcision.
Figure 4 Effect of ST intervention—as- treated analysis population. ST, self- testing; VMMC, voluntary medical male 
circumcision.
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VMMC cascade results—HCD-informed intervention 
segments
Men in the three prioritised segments (embarrassed 
rejecters, neophytes, enthusiasts) were more likely to be 
circumcised than those in the non- prioritised segments. 
Overall however, men in the green (default) segment 
were much more likely than any other segment to 
undergo circumcision (>70%) (see online supplemental 
figure 1).
HIVST secondary outcomes
In total, 3296 men were reached by IPC agents in the 
HIVST arms (ST and HCD+ST arms), of whom only 
8.6% (283/3296) were successfully followed by phone to 
ask questions about HIVST kit uptake and use. Overall, 
200/283 (70.6%) men reported being offered HIVST 
kits. There was weak evidence that participants in the 
HCD+ST arm were less likely to be offered kits compared 
with participants in the ST arm (OR 0.62, 95% CI 0.37 to 
1.04; p=0.07). Overall, 76.5% of men who were offered a 
kit accepted it and 92.2% (141/153) of those accepting 
reported using the kit, again with no evidence of differ-
ence between arms (table 3).
Process evaluation findings
Acceptability of the interventions
Most IPC agents allocated to the HCD- informed 
approach found it useful, noting that engaging one- 
on- one was more effective, resulting in more men getting 
quality information than was possible when using a 
group approach. However, all felt that some components 
(especially segmentation) lengthened the IPC session, 
resulting in fewer men ‘reached’ compared with using 
traditional IPC approaches.
Regarding HIVST, IPC agents felt that the interven-
tion generated huge interest in the communities where 
HIVST had not been previously available. There was high 
demand for HIVST across all five districts, which appeared 
to be independent of intention to get circumcised.
Uneven performance among IPC agents and districts
There were substantial differences in the performance 
of IPC agents across all outcomes. Only 105 (79.5%) of 
the 132 trained IPC agents reached at least one man to 
discuss VMMC over the course of the trial (and so were 
included in the ‘as- treated’ analysis) (see online supple-
mental table 3). Forty (38.1%) did not convert anyone to 
VMMC during the trial and 30 (28.6%) converted fewer 
than 6 men (one per month). Conversely, two IPC agents 
converted over 50 per month (one converted 553 over 6 
months and the other converted 355).
In addition to variability between IPC agents, there 
was variability in implementation between study districts 
(conversion proportion ranging from 6% in Zvimba 
to 81% in Buhera), possibly due to contextual factors 
including number of men who were eligible to be circum-
cised. IPC agents in Buhera and Gokwe North devoted 
considerable time to VMMC mobilisation, perhaps 
reflecting the lack of employment opportunities locally. 
In the other districts, IPC agents were involved in addi-
tional income- generating activities. These factors likely 
explain some of the variability observed between study 
districts (online supplemental table 5).
Implementation of the interventions
Implementation of the HCD- informed intervention was 
not always as intended. As segmentation lengthened 
the time for mobilisation, this resulted in some IPC 
agents resorting to traditional approaches or adminis-
tering an abridged and possibly suboptimal version of 
the approach. IPC agents also reported they were some-
times selective about which messages they delivered to 
each segment (eg, they left out messages they viewed as 
age and sexual experience inappropriate). Of note, IPC 
agent gender, age and education were significantly asso-
ciated with VMMC uptake (online supplemental table 4).
The HIVST intervention was similarly not implemented 
as intended. As IPC agents were the only source of ST 
kits in the RCT districts, they did not want to be seen 
as ‘promoting HIVST’ instead of VMMC, with the result 
that HIVST kits were not always offered by IPC agents in 
HIVST arms. This was in part because IPC agents some-
times reported that they felt men taking HIVST kits were 
not necessarily interested in VMMC. This may have been 
true; an appreciable proportion of the men we were able 
to follow- up by phone obtained ST kits and reportedly 
Table 3 Uptake of HIVST, by study arm (ST vs HCD+ST)
  
Arm 2: ST Arm 4: HCD+ST Effect of HCD+ST vs ST
n/N % n/N % OR (95% CI) P value
Men offered HIVST (% surveyed) 129/173 74.6 71/110 64.6 0.62 (0.37 to 1.04) 0.072
Men accepting HIVST (% offered) 101/129 78.3 52/71 73.2 0.76 (0.39 to 1.49) 0.420
Men using HIVST (% accepted) 91/101 90.1 50.52 96.2 2.75 (0.58 to 13.03) 0.203
Reactive HIVST (% used) 5/91 5.5 1/50 2.0 0.37 (0.04 to 3.30) 0.376 (0.072)*
Men with reactive test linked to care 
(% reactive)
2/5 40.0 1/1 100.0
*Fisher’s exact test.
HCD, human- centred design; HIVST, HIV self- testing; ST, self- testing.
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tested but did not take up VMMC. Further, ST kits were 
more likely to be offered in arm 2 (HIVST arm) than in 
arm 4 (HCD and HIVST), where the intervention took 
longest to deliver and which consequently had the highest 
data burden. IPC agents also found it difficult to incorpo-
rate the demonstration of the HIVST kit or the demon-
stration video into the IPC session. Of note, IPC agents 
received an incentive if their clients were circumcised but 
not if they self- tested, which may also have reduced their 
enthusiasm for HIVST distribution and demonstration.
DISCUSSION
We conducted a pragmatic randomised 2×2 factorial 
trial to determine the effectiveness of the HCD- informed 
approach and HIVST in motivating men (15–29 years) to 
take up VMMC. Our trial found no evidence that HCD- 
informed mobilisation or the offer of a HIVST kit prior to 
VMMC had an effect on VMMC uptake or on secondary 
outcomes.
The lack of detectable effect may be due to a number 
of factors. First, the market research conducted in 
2015 identified several barriers or facilitators to VMMC 
uptake and recommended a set of interventions be 
delivered through multiple channels.26–28 However, 
due to resource constraints, these multiple approaches 
were not feasible to implement in practice. The HCD- 
informed approach tested here only addressed a subset 
of barriers. For example, we know that fear of financial 
loss was not addressed and this could be an especially 
important barrier in settings where majority of men are 
self- employed. Recent systematic reviews9 30 have found 
that financial incentives framed as fair compensation 
(rather than as lottery) appear to be the most accept-
able and effective VMMC demand creation intervention 
found to date especially among adult men.
As stated earlier, men who were already deemed by 
IPC agents in HCD- informed approach arms to be highly 
motivated to VMMC and did not require the use of the 
segmentation typing tool were allocated to the ‘green’ 
segment. They had the highest rate of conversion to 
VMMC. We do not know what segment they would have 
been allocated to if the segmentation typing tool had 
been applied and so cannot determine if prioritised 
segments were indeed those most likely to be ‘easy to 
convert’. Of note, we have included the 12.6% classi-
fied in the ‘green’ category (and who therefore did not 
receive the intervention as planned) in the analyses, as 
no exclusion of men of this type in the no HCD- informed 
approach is possible.
It was assumed that once trained, every IPC agent 
would be able to implement the HCD- informed 
approach as intended. Field observation suggested that 
implementing the HCD- informed approach requires 
more education and skills than traditional approaches. It 
takes time for IPC agents to become familiar with using 
the tools and, indeed, some IPC agents selected for the 
trial never became comfortable with using the approach. 
Our process evaluation found that younger, male, and 
better- educated IPC agents appeared more successful 
at creating demand for VMMC using the approach. 
Further, as combining the HCD- informed approach and 
HIVST lengthened the IPC session and resulted in a 
higher data collection burden, it might not be feasible 
for the two approaches to be rolled out simultaneously 
going forward.
Perhaps important is that IPC agents were incentivised 
according to the national incentive structure (US$5 when 
a boy aged 10–14 years or a man ≥30 years was circum-
cised and US$7 when a man aged 15–29 years was circum-
cised). IPC agents could therefore earn larger amounts by 
converting groups of younger boys (eg, through schools) 
with relatively less effort than they could by spending 
longer time recruiting ‘recalcitrant’ adult men using the 
HCD- informed approach.
The power of the trial to show an impact was likely 
reduced by the fact that relatively few IPC agents (75 
out of 140 randomised) actually mobilised for VMMC, 
perhaps reflecting the acceptability and/or feasibility of 
delivering the interventions. Suboptimal supervision of 
implementation of the interventions, as indicated by a 
high number of inactive IPC agents, may have contrib-
uted. While the lower than anticipated VMMC conver-
sion rate may have affected the RCT’s ability to show an 
impact, there is no suggestion from the effect sizes of any 
impact of the HCD- informed approach.
The extent of variability between IPC agents in terms of 
performance was greater than anticipated. In addition, 
there was considerable imbalance in characteristics of 
IPC agents by arm because of the substitution of 20 IPC 
agents postrandomisation and differential drop out by 
arm. IPC agents’ characteristics were associated with rate 
of VMMC conversion, and this may have undermined the 
ability of the trial to demonstrate an impact.
Our trial is one of the first studies to rigorously eval-
uate an HCD- informed intervention and as delivered 
in a real- world and resource- constrained setting. More-
over, rigorous procedures were used to ascertain objec-
tively measured outcomes; the RCT was complemented 
by process evaluation including in- depth qualitative data 
collection to understand mechanisms of action. However, 
as with other evaluations of programmatic interventions, 
our trial was characterised by real life challenges to imple-
mentation including a lack of control of the manner in 
which interventions were implemented. Many of the 
challenges experienced in this trial are not unique to the 
interventions tested here, but are common during evalu-
ations of real- world interventions.31
In conclusion, the RCT did not show evidence of 
an effect of interventions on VMMC uptake. That the 
majority of IPC agents referred fewer than one man a 
month for VMMC suggests that they may not have been 
motivated to use these demand creation approaches as 
designed, which has implications for interventions’ feasi-
bility. Importantly, in order to appeal to adult men, other 
research9 30 has suggested that VMMC demand creation 
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interventions should include financial incentives 
framed as fair compensation. Trial findings will inform 
future design and implementation of demand creation 
evaluations.
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